UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Loss of endogenous thymosin β4 accelerates glomerular disease

Vasilopoulou, E; Kolatsi-Joannou, M; Lindenmeyer, MT; White, KE; Robson, MG; Cohen, CD; Sebire, NJ; ... Long, DA; + view all (2016) Loss of endogenous thymosin β4 accelerates glomerular disease. Kidney International , 90 (5) pp. 1056-1070. 10.1016/j.kint.2016.06.032. Green open access

[thumbnail of Supplementary table]
Preview
Text (Supplementary table)
Vasilopoulou et al 2016 Loss of endogenous thymosin b4 accelerates glomerular disease Table.pdf

Download (128kB) | Preview
[thumbnail of Supplementary figures] Slideshow (Supplementary figures)
Vasilopoulou et al 2016 Loss of endogenous thymosin b4 accelerates glomerular disease Supplementary figs.ppt

Download (2MB)
[thumbnail of 1-s2.0-S008525381630326X-main.pdf]
Preview
Text
1-s2.0-S008525381630326X-main.pdf

Download (5MB) | Preview

Abstract

Glomerular disease is characterized by morphologic changes in podocyte cells accompanied by inflammation and fibrosis. Thymosin β4 regulates cell morphology, inflammation, and fibrosis in several organs and administration of exogenous thymosin β4 improves animal models of unilateral ureteral obstruction and diabetic nephropathy. However, the role of endogenous thymosin β4 in the kidney is unknown. We demonstrate that thymosin β4 is expressed prominently in podocytes of developing and adult mouse glomeruli. Global loss of thymosin β4 did not affect healthy glomeruli, but accelerated the severity of immune-mediated nephrotoxic nephritis with worse renal function, periglomerular inflammation, and fibrosis. Lack of thymosin β4 in nephrotoxic nephritis led to the redistribution of podocytes from the glomerular tuft toward the Bowman capsule suggesting a role for thymosin β4 in the migration of these cells. Thymosin β4 knockdown in cultured podocytes also increased migration in a wound-healing assay, accompanied by F-actin rearrangement and increased RhoA activity. We propose that endogenous thymosin β4 is a modifier of glomerular injury, likely having a protective role acting as a brake to slow disease progression.

Type: Article
Title: Loss of endogenous thymosin β4 accelerates glomerular disease
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.kint.2016.06.032
Publisher version: http://dx.doi.org/10.1016/j.kint.2016.06.032
Language: English
Additional information: Copyright © 2016, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: cytoskeleton, fibrosis, glomerulus, inflammation, podocyte
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery-pp.ucl.ac.uk/id/eprint/1501174
Downloads since deposit
13,072Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item